Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.10.0.1
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Income Statement [Abstract]    
Net Sales $ 32,000 $ 6,000
Operating Expenses:    
Cost of revenue 52,000 8,000
Research and development 980,000 375,000
General and administrative 6,792,000 4,328,000
Total operating expenses (7,824,000) (4,711,000)
Loss from operations (7,792,000) (4,705,000)
Other income (expense)    
Other Income / (Expense) (5,000) 28,000
Financing costs (798,000) (643,000)
Interest expense - amortization of debt discount (1,468,000) (418,000)
Change in fair value of derivative liability (1,167,000) 6,000
Debt extinguishment, net (534,000) (977,000)
Interest expense (including $211,000 and $236,000 to related parties) (362,000) (555,000)
Total other expense (4,334,000) (2,559,000)
Loss before income tax provision (12,126,000) (7,264,000)
Income tax provision 1,000 2,000
Net Loss $ (12,127,000) $ (7,266,000)
Loss per share - basic and diluted $ (1.23) $ (1.03)
Weighted average number of common shares outstanding - basic and diluted 9,870,890 7,076,540